Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients
Open Access
- 1 September 2014
- journal article
- review article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 20, 109-118
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Epstein–Barr Virus Infection and Posttransplant Lymphoproliferative DisorderAmerican Journal of Transplantation, 2013
- Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk PatientsTransplantation and Cellular Therapy, 2011
- Risk factors for early‐onset and late‐onset post‐transplant lymphoproliferative disorder in kidney recipients in the United StatesAmerican Journal of Hematology, 2010
- The Epstein-Barr Virus (EBV)-Encoded Protein Kinase, EBV-PK, but Not the Thymidine Kinase (EBV-TK), Is Required for Ganciclovir and Acyclovir Inhibition of Lytic Viral ProductionJournal of Virology, 2010
- Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative DisorderClinical Microbiology Reviews, 2010
- Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern EraJournal of Clinical Oncology, 2010
- Dissociation of Depletional Induction and Posttransplant Lymphoproliferative Disease in Kidney Recipients Treated With AlemtuzumabAmerican Journal of Transplantation, 2007
- Treatment of solid organ transplant recipients with autologous Epstein Barr virus–specific cytotoxic T lymphocytes (CTLs)Blood, 2006
- Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patientsTransplantation, 2002
- Guide to Development of Practice GuidelinesClinical Infectious Diseases, 2001